Particulars |
|
|
|
Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
98.90 |
Sales(₹ Cr.) |
3,407.25 |
NP (₹ Cr.) |
651.27 |
NP Var (%) |
11.00 |
Div% |
320.00 |
CPS(₹) |
42.60 |
EPS (₹) |
38.40 |
Traded Value(₹ Lakhs) |
489.08 |
52 Week High |
3,147.00 |
52 Week Low |
1,924.00 |
Price BSE |
2,959.00 |
Price NSE |
2,965.00 |
Market Capital (₹ Cr.) |
50,134.87 |
P/C Ratio |
69.50 |
P/E Ratio |
77.00 |
Price Vs.BV |
29.92 |
|
Latest Quarter |
Year End |
202412 |
Sales (₹ Cr.) |
946.36 |
NP(₹ Cr.) |
228.58 |
NP Var % |
29.00 |
Trailing Twelve Months |
Year End |
202412 |
Sales |
3,526.90 |
OPM |
24.12 |
NP |
795.84 |
NP Var (%) |
33.25 |
EPS |
49.99 |
PE |
59.20 |
|
|